Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 2019
has subject area
- Aged (MeSH)
- Cardiovascular Diseases (MeSH)
- Clinical Trials as Topic (MeSH)
- Combined Modality Therapy (MeSH)
- Comorbidity (MeSH)
- Diabetes Complications (MeSH)
- Diabetes Mellitus, Type 2 (MeSH)
- Dyslipidemias (MeSH)
- Female (MeSH)
- Glucagon-Like Peptides (MeSH)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Immunoglobulin Fc Fragments (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Multicenter Studies as Topic (MeSH)
- Primary Health Care (MeSH)
- Recombinant Fusion Proteins (MeSH)
- Risk Factors (MeSH)
- Smoking (MeSH)
- Spain (MeSH)